Role of bronchoalveolar lavage in interstitial lung disease

Clinics in Chest Medicine

Volumn 22, Issue 2, 2001, Pages 331-341

  Baughman, Robert P ^a   Drent, Marjolein ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; DIAGNOSTIC VALUE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG LAVAGE; LYMPHOCYTE COUNT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0034954953     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70047-2     Document Type: Article

References (113)

1. CD8 alveolitis in sarcoidosis: Incidence, phenotypic characteristics, and clinical features
2. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils
3. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure
4. Hypersensitivity pneumonitis
5. Difference in the phenotypes of bronchoalveolar lavage lymphocytes in patients with summer-type hypersensitivity pneumonitis, farmer's lung, ventilation pneumonitis, and bird fancier's lung: Report of a nationwide epidemiologic study in Japan
6. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups
7. Ultrastructural examination of broncho-alveolar lavage for diagnosis of pulmonary histiocytosis X: Preliminary report on four cases
8. Sarcoidosis. Usual and unusual manifestations
9. The uncertainties of bronchoalveolar lavage
10. Is bronchoalveolar lavage clinically useful for everyday practice in interstitial lung disease? Pro: Bronchoalveolar lavage
11. Systemic immune response of patients with active pulmonary sarcoidosis
12. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis
13. Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis
14. Bronchoalveolar lavage sampling and general approaches to correction for variability of dilution and lung permeability
15. The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients
16. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections
17. Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy
18. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: Prognostic indicators
19. Relationship between interleukin-8 and neutrophils in the BAL fluid of sarcoidosis
20. Spontaneous hydrogen peroxide release from alveolar macrophages of patients with active sarcoidosis: Comparison with cigarette smokers
21. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis
22. Th1/Th2 cell distribution in pulmonary sarcoidosis
23. Analysis of mineral particles recovered by bronchoalveolar lavage for diagnosis of dust related lung diseases
24. Effects of smoking and irradiated volume on inflammatory response in the lung of irradiated breast cancer patients evaluated with bronchoalveolar lavage
25. Inflammatory cytokines in cystic fibrosis lungs
26. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome
27. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
28. Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction
29. Alveolar T-cell subsets in pulmonary sarcoidosis: Correlation with disease activity and effect of steroid treatment
30. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: Comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush
31. Diagnosis of pulmonary histiocytosis X by immumodetection of Langerhans cells in bronchoalveolar lavage fluid
32. Bronchoalveolar lavage for the preparation of free lung cells: Technique and complications
33. Pneumonia in immunocompromised and immunocompetent patients requiring mechanical ventilation
34. Abnormal bronchoalveolar lavage in asymptomatic dairy farmers. Study of lymphocytes
35. Bronchoalveolar lavage in farmers' lung disease: Diagnostic and physiological significance
36. CD4/CD8 ratios in bronchoalveolar lavage fluid: Of value for diagnosing sarcoidosis?
37. Bronchiolitis obliterans organizing pneumonia (BOOP): The cytological and immunocytological profile of bronchoalveolar lavage
38. Pulmonary sarcoidosis: A disease characterized and perpetuated by activated lung T-lymphocytes
39. Immunologic abnormalities in sarcoidosis
40. Diagnostic value of asbestos bodies of bronchoalveolar lavage fluid
41. The association of man-made mineral fibre exposure and sarcoidlike granulomas
42. Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis
43. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases
44. Bronchoalveolar lavage fluid profiles in sarcoidosis, tuberculosis, and non-Hodgkin's and Hodgkin's disease. An evaluation of differences
45. Inhaled budesonide influences cellular and biochemical abnormalities in pulmonary sarcoidosis
46. Bronchoalveolar lavage eosinophilia associated with Pneumocystis carinii pneumonitis in AIDS patients. Comparative study with non-AIDS patients
47. Paclitaxel-induced cell-mediated hypersensitivity pneumonitis. Diagnosis using leukocyte migration test, bronchoalveolar lavage and transbronchial lung biopsy
48. Predictive value of bronchoalveolar lavage cells and serum precipitins in asymptomatic dairy farmers
49. Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis
50. Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia: A prospective study among patients with acquired immunodeficiency syndrome
51. Patients with collagen vascular disease and dyspnea. The value of gallium scanning and bronchoalveolar lavage in predicting response to steroid therapy and clinical outcome
52. Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases
53. The clinical role of BAL in idiopathic pulmonary fibrosis
54. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy
55. The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV
56. Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful?
57. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis
58. Mechanisms of hypergammaglobinemia in pulmonary sarcoidosis: Site of increased antibody production and role of Tlymphocyte
59. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity
60. Bronchoalveolar mast cells in summer-type hypersensitivity pneumonitis: Increase in numbers and ultrastructural evidence of degranulation
61. Sarcoidosis, tuberculosis, and tuberculin anergy. A prospective study
62. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis
63. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance
64. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification
65. Detection of lymphomatous involvement of the lung by bronchoalveolar lavage. Application of immunophenotypic and gene rearrangement analysis
66. The alveolitis of pulmonary sarcoidosis: Evaluation of natural history and alveolitis-dependent changes in lung function
67. The handling and analysis of bronchoalveolar lavage specimens
68. Clinical guidelines and indications for bronchoalveolar lavage (BAL)
69. Technical recommendations and guidelines for bronchoalveolar lavage (BAL)
70. Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis
71. Bronchoscopic diagnosis of sarcoidosis
72. A study of sarcoidosis based on a combined investigation of 160 cases including 30 autopsies
73. Pulmonary lymphangitic metastasis from breast cancer. Lymphocytic alveolitis is associated with favorable prognosis
74. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8
75. Pulmonary alveolar microlithiasis: Review of Italian reports
76. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis
77. Expression of pro-inflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia
78. Manifestations of sarcoidosis
79. Enhanced expression of IL-12 associated with Th 1 cytokine profiles in active pulmonary sarcoidosis
80. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease
81. Bronchoalveolar lavage in acute phenytoin hypersensitivity pneumonitis
82. Primary pulmonary B-cell lymphoma diagnosed by κ-λ imaging of bronchoalveolar lavage fluid lymphocytes
83. Transbronchial lung biopsy in the diagnosis of suspected ocular sarcoidosis
84. Prognostic role of eosinophils in pulmonary fibrosis
85. Spontaneous release of interleukin-2 by lung lymphocytes in active pulmonary sarcoidosis
86. Corticosteroid therapy suppresses spontaneous interleukin-2 release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis
87. Bronchoalveolar lavage in the diagnosis of peripheral, primary lung cancer
88. Pulmonary alveolar phospholipoproteinosis: Experience with 34 cases and a review
89. 2 release, alveolitis, and disease severity in sarcoidosis
90. Breast carcinoma in bronchoalveolar lavage. A cytologic and immunocytochemical study
91. Is bronchoalveolar lavage clinically useful for everyday practice in interstitial lung disease?: Con bronchoalveolar lavage
92. Use of a central laboratory for analysis of bronchoalveolar lavage fluid
93. Bronchoalveolar lavage
94. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage
95. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients
96. γ-Interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis
97. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease
98. Cryptogenic fibrosing alveolitis: Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis
99. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis
100. Approach to the understanding, diagnosis, and management of interstitial lung disease
101. Bronchoalveolar lavage and lung histology: Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis
102. Bronchoalveolar lavage studies in uveitis patients without radiological intrathoracic involvement of sarcoidosis
103. Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: Correlation with the clinical parameters
104. Imbalance between Pneumocystis carinii cysts and zoites in bronchoalveolar lavage fluid from patients receiving prophylaxis
105. Current concepts of the pathogenesis of sarcoidosis
106. Bronchoalveolar lavage as a research tool
107. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis
108. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid
109. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis
110. Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis
111. Sarcoidosis: Analysis of cells obtained by bronchial lavage
112. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis
113. Sarcoidosis: Historical perspective and immunopathogenesis (part I)